South and Central America Pharmacogenomics Market to Grow at a CAGR of 10.5% to reach US$ 591.35 Million from 2021 to 2028

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South and Central America Pharmacogenomics Market – By Technology

1.3.2 South and Central America Pharmacogenomics Market – By Application

1.3.3 South and Central America Pharmacogenomics Market – By End User

1.3.4 South and Central America Pharmacogenomics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Pharmacogenomics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South And Central America PEST Analysis

4.3 Experts Opinion

5. Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Funding for Pharmacogenomics

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increasing Demand for Third Generation Sequencing

5.4 Future Trends

5.4.1 Increasing Demand for Personalized Medicines

6. Pharmacogenomics Market–South and Central America Analysis

6.1 South and Central America Pharmacogenomics Market Revenue Forecast and Analysis

7. Pharmacogenomics Market Revenue and Forecasts To 2028 – Technology

7.1 Overview

7.2 Pharmacogenomics Market Share by Technology - 2021 & 2028 (%)

7.3 Polymerase Chain Reaction

7.3.1 Overview

7.3.2 Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.3 Real Time PCR

7.3.3.1 Overview

7.3.3.2 Real Time PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.4 Standard PCR

7.3.4.1 Overview

7.3.4.2 Standard PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.5 Digital PCR

7.3.5.1 Overview

7.3.5.2 Digital PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.4 Sequencing

7.4.1 Overview

7.4.2 Sequencing: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.5 Microarray

7.5.1 Overview

7.5.2 Microarray: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.6 Gel Electrophoresis

7.6.1 Overview

7.6.2 Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.7 Mass Spectrometry

7.7.1 Overview

7.7.2 Mass Spectrometry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8. Pharmacogenomics Market Revenue and Forecasts To 2028– by Application

8.1 Overview

8.2 Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

8.3 Drug Discovery

8.3.1 Overview

8.3.2 Drug Discovery: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology & Psychiatry

8.5.1 Overview

8.5.2 Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Pain Management

8.6.1 Overview

8.6.2 Pain Management: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Cardiovascular Disease

8.7.1 Overview

8.7.2 Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9. Pharmacogenomics Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 Global Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Biopharmaceutical Companies

9.4.1 Overview

9.4.2 Biopharmaceuticals Companies: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.5 CROs and CDMOs

9.5.1 Overview

9.5.2 CROs and CDMOs: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

10. Pharmacogenomics Market Revenue and Forecasts to 2028 – Country Analysis

10.1 South And Central America Pharmacogenomics Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.2 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.3.1 South and Central America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.4 South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.5 South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)

10.1.6.1 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.6.1.3 Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.6.1.3.1 Argentina: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.1.4 Argentina: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.6.1.5 Argentina: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.6.2.3 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.6.2.3.1 Brazil: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.2.4 Brazil: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.6.2.5 Brazil: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3 Rest of South and Central America: Pharmacogenomics Market– Revenue and Forecast to 2028 (USD Mn)

10.1.6.3.1 Overview

10.1.6.3.2 Rest of South and Central America: Pharmacogenomics Market– Revenue and Forecast to 2028 (USD Mn)

10.1.6.3.3 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.6.3.3.1 Rest of South & Central America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.3.4 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.6.3.5 Rest of South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on South and Central America Pharmacogenomics Market

11.1 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Oxford Nanopore Technologies

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Illumina, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 2. South and Central America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 3. South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 4. South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 5. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 6. Argentina: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 7. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 8. Argentina: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 9. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. Brazil: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 11. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 12. Brazil: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14. Rest of South & Central America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 16. Rest of South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Organic Developments Done by Companies

Table 18. Inorganic Developments Done By Companies

Table 19. Glossary of Terms

LIST OF FIGURES

Figure 1. Pharmacogenomics Market Segmentation

Figure 2. Pharmacogenomics Market, By Country

Figure 3. South and Central America Pharmacogenomics Market Overview

Figure 4. PCR Segment Held Largest Share of Technology Segment in Pharmacogenomics Market

Figure 5. South and Central America Pharmacogenomics Market- Leading Country Markets (US$ Million)

Figure 6. South And Central America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. South and Central America Pharmacogenomics Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 9. Pharmacogenomics Market Share by Segment - 2021 & 2028 (%)

Figure 10. Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 11. Real Time PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 12. Standard PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 13. Digital PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 14. Sequencing: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15. Microarray: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16. Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Mass Spectrometry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

Figure 20. Drug Discovery: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. Oncology: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Pain Management: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Global Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

Figure 27. Hospital and Clinics: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Biopharmaceutical Companies: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. CROs and CDMOs: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. South and Central America Pharmacogenomics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 32. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)

Figure 34. Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. Rest of South and Central America: Pharmacogenomics Market– Revenue and Forecast to 2028 (USD Mn)

Figure 37. Impact of COVID-19 Pandemic in South and Central America Country Markets